GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Novartis NOVN.SW · CHF

Health Care · Pharmaceuticals · SIX · 🇨🇭 Switzerland

Compare

133.46

+0.29%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Novartis annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In USD.

FY2025FY2024FY2023FY2022FY2021
Revenue$46.49bn$42.10bn$37.98bn$35.37bn$35.79bn
Operating income$14.48bn$11.84bn$7.95bn$6.47bn$8.91bn
Net income$11.92bn$9.72bn$12.09bn$5.66bn$19.55bn
Free cash flow$15.00bn$11.24bn$9.53bn$9.41bn$9.85bn
Total assets$94.00bn$83.22bn$81.34bn$95.59bn$107.27bn
Shareholders' equity$37.52bn$35.85bn$37.98bn$48.30bn$55.06bn

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.